Erdafitinib CAS 1346242-81-6 – Product Details and Technical Information

About Erdafitinib

Erdafitinib is a small-molecule compound with the chemical identifier CAS 1346242-81-6 and molecular formula C25H30N6O2. It is recognized for its inhibitory activity against certain fibroblast growth factor receptors (FGFRs), a group of proteins involved in cellular communication and growth-related signaling.

FGFR proteins help regulate how cells respond to external signals. Changes in these signaling pathways have attracted attention in biomedical research. Erdafitinib has an established background in FGFR-targeted cancer treatment and is also a subject of scientific investigation involving receptor activity and molecular signaling.

For chemical procurement, accurate identification and reliable technical information are essential. This product is specified as a white powder with a stated purity above 99%. HPLC-UV is the analytical method listed in the supplied product data. Buyers can review the relevant batch documentation to assess whether the material meets their requirements.

Erdafitinib Technical Specifications

Chemical Properties and Quality Information

Chemical Identification

The CAS number is a standardized reference used to distinguish chemical substances. For Erdafitinib, this number is 1346242-81-6. Its molecular formula, C25H30N6O2, provides additional information about its chemical composition.

These details are useful when checking quotations, comparing suppliers, preparing purchasing records, and reviewing technical documents. Buyers should ensure that the product label and analytical records refer to the same compound.

Purity and Testing

The stated purity specification is greater than 99%. For buyers who need to evaluate product quality, the certificate of analysis (COA) is an important reference.

The listed analytical technique is HPLC-UV. This method combines chromatographic separation with ultraviolet detection to analyze suitable compounds in a sample. The actual result should be interpreted according to the test procedure and acceptance criteria.

A purity value does not independently confirm every quality characteristic. Additional testing may be needed for parameters such as residual solvents, water content, or specific impurities, depending on the intended application.

Physical Appearance

Erdafitinib is supplied in powder form according to the provided specification. Its listed color is white. Appearance is useful for routine inspection, but it should not replace analytical testing when confirming chemical identity or purity.

Research Background and Potential Applications

Erdafitinib is associated with FGFR inhibition, making it relevant to scientific research involving receptor signaling and related molecular mechanisms.

FGFR-related studies examine how receptor proteins participate in cellular processes and how changes in their activity may influence biological systems. Erdafitinib's established pharmacological background provides context for its importance in research literature concerning targeted receptor inhibition.

Its suitability for a particular research or development project depends on the verified material grade, analytical results, and project-specific requirements. Technical-grade chemical material should not automatically be regarded as suitable for pharmaceutical manufacturing, clinical use, or human administration.

Packaging, Storage and Handling

Different purchasing quantities may require different packaging arrangements. The listed options include 1 g, 100 g, 1 kg, and 25 kg formats. Actual availability and packaging suitability should be confirmed before ordering.

The supplied information specifies storage at 2–8°C, protected from light and kept tightly sealed. Buyers should verify these conditions against the current technical documentation before storage.

When handling chemical powders, follow the relevant safety data sheet (SDS). Appropriate protective equipment, secure container closure, and suitable handling procedures should be used.

The stated two-year retest period requires supporting stability documentation before it is presented as a confirmed shelf-life claim.

Supply and Purchasing Information

When requesting a quotation, buyers can provide the required quantity, preferred package size, delivery destination, and documentation requirements.

The estimated delivery lead time is 5–10 days, subject to stock and order confirmation. Air or sea transport may be considered depending on the destination, carrier acceptance, and applicable customs and shipping regulations.

Customized packaging and sample requests can be discussed in advance. Confirming the specifications and shipping arrangements before purchase helps both parties establish clear expectations.

Frequently Asked Questions

1. What is the CAS number of Erdafitinib?

The CAS number is 1346242-81-6.

2. What is the molecular formula?

Its molecular formula is C25H30N6O2.

3. What purity is specified?

The supplied product information states greater than 99% purity. Please refer to the batch COA for the actual result.

4. Which analytical method is used?

HPLC-UV is the listed analytical method.

5. What packaging options are available?

The listed formats include 1 g, 100 g, 1 kg, and 25 kg, subject to confirmation.

6. How can I obtain a quotation?

Provide your required quantity, preferred packaging, destination country, and documentation requirements to confirm availability and delivery arrangements.

Final Product Summary

Erdafitinib CAS 1346242-81-6 is a small-molecule compound associated with FGFR inhibition. Its supplied specifications include a molecular formula of C25H30N6O2, powder appearance, stated purity above 99%, and HPLC-UV analytical testing. Buyers should review batch-specific quality records and confirm storage, packaging, and regulatory requirements before purchase.